Related Experiment Video
Updated: Jul 6, 2026

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
Published on: October 1, 2012
Sex-based differences in vascular repair with bone marrow cell therapy: relevance of regulatory and Th2-type
A G Zenovich1, A Panoskaltsis-Mortari, G J Caron
1Center for Cardiovascular Repair, Section of Pediatric Bone Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
Insights
Female bone marrow mononuclear cells (BM-MNCs) protected male mice from atherosclerosis. However, BM-MNCs did not reduce plaque in female mice, suggesting sex-based differences in cell therapy for coronary artery disease (CAD).
Area of Science:
- Cardiovascular Research
- Immunology
- Regenerative Medicine
Background:
- Coronary artery disease (CAD) exhibits sex-based differences in symptoms and treatment efficacy.
- Clinical outcomes of cell therapy for CAD are variable.
- The impact of sex on cell therapy response in CAD remains unclear.
Purpose of the Study:
- To investigate sex-specific differences in the efficacy of bone marrow mononuclear cells (BM-MNCs) for treating atherosclerosis.
- To explore the role of sex in response to cell therapy in a mouse model of atherosclerosis.
Main Methods:
- Atherosclerotic apolipoprotein E-knockout (ApoE-/-) mice of both sexes received intravenous injections of male or female BM-MNCs or vehicle.
- Aortic plaque burden was quantified.
- Bone marrow progenitor cell profiles and circulating cytokine levels were analyzed.
Main Results:
- Female BM-MNCs demonstrated atheroprotective effects in male ApoE-/- mice.
- No significant reduction in plaque lesions was observed in female ApoE-/- mice treated with BM-MNCs from either sex.
- Increased levels of granulocyte-colony stimulating factor (G-CSF) correlated with reduced plaque burden.
Conclusions:
- Sex-based differences exist in the atheroprotective response to BM-MNC therapy.
- Female BM-MNCs may hold potential for treating atherosclerosis in males.
- Further research is needed to understand the mechanisms underlying sex differences in vascular repair and cell therapy for CAD.
Objectives:
There are differences in symptoms, risk stratification, and efficacy of pharmacological treatments between men and women with coronary artery disease (CAD). The results of clinical studies of cell therapy in CAD patients are mixed. The relevance of sex to response to cell therapy is unknown. We investigated sex-based differences in response to bone marrow mononuclear cells (BM-MNCs) in atherosclerotic apoliproprotein E-knockout (ApoE -/-) mice.
Methods:
Twenty-three male and 27 female ApoE -/- mice fed on a high-fat diet received four intravenous BM-MNC injections (C57BL6/J mice) starting at 14 weeks of age; male or female BM-MNCs were administered. Thirteen male and 20 female atherosclerotic ApoE -/- mice received vehicle. Aortic plaque burden (%), recipient bone marrow progenitor cell profiles (FACS-LSR II, FlowJo) and 22 circulating cytokine panel (LINCOplex) were quantified and analyzed statistically (SSPS, P < or 5).
Results:
Quantitative and semiquantitative results are presented. Increased G-CSF levels correlated with plaque reduction (r = -.86, P = .0004). G-CSF was clustered with IL-15.
Conclusions:
Female but not male BM-MNCs exhibited atheroprotection in male atherosclerotic ApoE -/- mice. Plaque lesions did not attenuate atherosclerosis in female ApoE -/- mice with BM-MNCs of either donor sex. An increase in regulatory and in Th2-type response may be required for atheroprotection. Sex-based differences in vascular repair have implications for cell therapy trials in CAD.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Mesenchymal Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
